|
WO1999051208A1
(en)
|
1998-04-03 |
1999-10-14 |
Bm Research A/S |
Controlled release composition
|
|
DE60224293T2
(de)
*
|
2001-09-21 |
2008-12-11 |
Egalet A/S |
Feste dispersionen mit kontrollierter freisetzung von carvedilol
|
|
WO2003024430A1
(en)
|
2001-09-21 |
2003-03-27 |
Egalet A/S |
Morphine polymer release system
|
|
WO2003024429A1
(en)
|
2001-09-21 |
2003-03-27 |
Egalet A/S |
Polymer release system
|
|
US8101209B2
(en)
*
|
2001-10-09 |
2012-01-24 |
Flamel Technologies |
Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
|
|
CA2483054A1
(en)
*
|
2002-04-30 |
2003-11-13 |
Sb Pharmco Puerto Rico Inc. |
Carvedilol monocitrate monohydrate
|
|
US7268156B2
(en)
|
2002-06-27 |
2007-09-11 |
Sb Pharmco Puerto Rico Inc. |
Carvedilol phosphate salts and/or solvates thereof, corresponding compositions and/or methods of treatment
|
|
CA2492084A1
(en)
|
2002-06-27 |
2004-01-08 |
Sb Pharmco Puerto Rico Inc. |
Carvedilol hydobromide
|
|
WO2004041252A1
(en)
*
|
2002-11-08 |
2004-05-21 |
Egalet A/S |
Controlled release carvedilol compositions
|
|
AU2003283789A1
(en)
*
|
2002-11-22 |
2004-06-18 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Beta-blockers having antioxidant and nitric oxide-donor activity
|
|
CA2520312C
(en)
*
|
2003-03-26 |
2013-06-18 |
Egalet A/S |
Matrix compositions for controlled delivery of drug substances
|
|
ATE495732T1
(de)
|
2003-03-26 |
2011-02-15 |
Egalet As |
Morphin-system mit kontrollierter freisetzung
|
|
WO2004093850A1
(en)
*
|
2003-04-24 |
2004-11-04 |
Jagotec Ag |
Tablet with coloured core
|
|
US7260685B2
(en)
|
2003-06-20 |
2007-08-21 |
Micron Technology, Inc. |
Memory hub and access method having internal prefetch buffers
|
|
AU2004279318C1
(en)
*
|
2003-09-12 |
2020-06-25 |
Amgen Inc. |
Rapid dissolution formulation of a calcium receptor-active compound
|
|
US7120743B2
(en)
|
2003-10-20 |
2006-10-10 |
Micron Technology, Inc. |
Arbitration system and method for memory responses in a hub-based memory system
|
|
EP1691789B1
(en)
|
2003-11-25 |
2017-12-20 |
SmithKline Beecham (Cork) Limited |
Carvedilol free base, salts, anhydrous forms or solvate thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
|
|
EP1686986A4
(en)
|
2003-11-25 |
2009-05-27 |
Sb Pharmco Inc |
CARVEDILOL SALTS, CORRESPONDING COMPOSITIONS, METHODS OF ADMINISTRATION AND / OR TREATMENT
|
|
JP2007512350A
(ja)
*
|
2003-11-25 |
2007-05-17 |
エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド |
カルベジロール組成物の治療および送達方法
|
|
EP1750717B1
(en)
*
|
2004-02-11 |
2017-07-19 |
Rubicon Research Private Limited |
Controlled release pharmaceutical compositions with improved bioavailability
|
|
JP5161075B2
(ja)
*
|
2005-06-03 |
2013-03-13 |
エガレット エイ／エス |
分散媒体の第１フラクションとマトリックスの第２フラクションを有し、第２フラクションが胃腸の液体に少なくとも部分的に最初に曝される固形の医薬組成物
|
|
US8367112B2
(en)
*
|
2006-02-28 |
2013-02-05 |
Alkermes Pharma Ireland Limited |
Nanoparticulate carverdilol formulations
|
|
WO2007144785A2
(en)
*
|
2006-03-26 |
2007-12-21 |
Uti Limited Partnership |
Ryanodine receptor inhibitors and methods relating thereto
|
|
ES2400446T5
(es)
|
2006-08-03 |
2017-03-13 |
Horizon Pharma Ag |
Tratamiento con glucocorticoides de liberación retardada de una enfermedad reumática
|
|
US20090028935A1
(en)
*
|
2006-12-01 |
2009-01-29 |
Kristin Arnold |
Carvedilol forms, compositions, and methods of preparation thereof
|
|
WO2008070072A2
(en)
*
|
2006-12-01 |
2008-06-12 |
Mutual Pharmaceutical Company, Inc. |
Carvedilol forms, compositions, and methods of preparation thereof
|
|
CA2930487A1
(en)
*
|
2007-01-16 |
2008-07-24 |
Egalet Ltd. |
Use of i) a polyglycol and ii) an active drug substance for the preparation of a pharmaceutical composition for i)mitigating the risk of alcohol induced dose dumping and/or ii) reducing the risk of drug abuse
|
|
WO2008114276A1
(en)
*
|
2007-03-16 |
2008-09-25 |
Lupin Limited |
Novel oral controlled release composition of carvedilol
|
|
BRPI0701904A2
(pt)
*
|
2007-04-27 |
2008-12-09 |
Libbs Farmaceutica Ltda |
forma farmacÊutica de liberaÇço controlada de princÍpios ativos com solubilidade dependente do baixo ph do meio e processo para preparar a forma farmacÊutica
|
|
EP2155167A2
(en)
|
2007-06-04 |
2010-02-24 |
Egalet A/S |
Controlled release pharmaceutical compositions for prolonged effect
|
|
EP2391369A1
(en)
*
|
2009-01-26 |
2011-12-07 |
Nitec Pharma AG |
Delayed-release glucocorticoid treatment of asthma
|
|
WO2010089132A1
(en)
|
2009-02-06 |
2010-08-12 |
Egalet A/S |
Immediate release composition resistant to abuse by intake of alcohol
|
|
EP2445487A2
(en)
|
2009-06-24 |
2012-05-02 |
Egalet Ltd. |
Controlled release formulations
|
|
TWI415604B
(zh)
*
|
2009-09-29 |
2013-11-21 |
Tsh Biopharm Corp Ltd |
調控釋放卡菲蒂羅劑型
|
|
WO2011102506A1
(ja)
*
|
2010-02-22 |
2011-08-25 |
第一三共株式会社 |
経口用徐放性固形製剤
|
|
TW201141544A
(en)
|
2010-02-22 |
2011-12-01 |
Daiichi Sankyo Co Ltd |
Oral solid extended release dosage form
|
|
NZ704011A
(en)
|
2012-07-06 |
2016-04-29 |
Egalet Ltd |
Abuse deterrent pharmaceutical compositions for controlled release
|
|
CA2883077C
(en)
|
2012-09-03 |
2017-03-07 |
Daiichi Sankyo Company, Limited |
Hydromorphone hydrochloride-containing oral sustained-release pharmaceutical composition
|
|
KR102241487B1
(ko)
|
2013-02-20 |
2021-04-16 |
주식회사 종근당 |
제어방출 펠릿으로 된 약제학적 조성물
|
|
KR102158339B1
(ko)
|
2016-02-05 |
2020-09-21 |
삼진제약주식회사 |
인습성이 개선된 카르베딜롤 속방성 제제
|